Alternative State-Level Financing for Hepatitis CTreatment—The “Netflix Model”
Drug prices in the United States remain the highest in the world. New payment approaches are needed, a point illustrated by the new treatments for hepatitis C virus...
Verdant’s projects examine how federal policies, market structure, and drug-level economics shape the pharmaceutical market and supply chain. Our portfolio includes grant-funded research, advisory engagements, and expert testimony in pharmaceutical matters.
The 15 Drugs to be Negotiated by Medicare for 2028
On January 27, 2026, the Centers for Medicare & Medicaid Services announced the next round of drugs to be negotiated by Medicare. This round includes 15 drugs withnegotiated...
Lead with Evidence
Partner with Verdant for rigorous, objective economic analysis.